Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: a novel class of highly potent nicotinic receptor ligands.

Breining SR, Melvin M, Bhatti BS, Byrd GD, Kiser MN, Hepler CD, Hooker DN, Zhang J, Reynolds LA, Benson LR, Fedorov NB, Sidach SS, Mitchener JP, Lucero LM, Lukas RJ, Whiteaker P, Yohannes D.

J Med Chem. 2012 Nov 26;55(22):9929-45. doi: 10.1021/jm3011299. Epub 2012 Oct 17.

PMID:
23025891
2.

Application of system-level root cause analysis for drug quality and safety problems: a case study.

Sauer BC, Hepler CD.

Res Social Adm Pharm. 2013 Jan-Feb;9(1):49-59. doi: 10.1016/j.sapharm.2012.02.005. Epub 2012 May 2.

PMID:
22554397
3.

Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine.

Hauser TA, Hepler CD, Kombo DC, Grinevich VP, Kiser MN, Hooker DN, Zhang J, Mountfort D, Selwood A, Akireddy SR, Letchworth SR, Yohannes D.

Neuropharmacology. 2012 Jun;62(7):2239-50. doi: 10.1016/j.neuropharm.2012.01.009. Epub 2012 Jan 27.

PMID:
22306792
4.

A dream deferred.

Hepler CD.

Am J Health Syst Pharm. 2010 Aug 15;67(16):1319-25. doi: 10.2146/ajhp100329. No abstract available.

PMID:
20689120
5.

Computerized indicators of potential drug-related emergency department and hospital admissions.

Sauer BC, Hepler CD, Cherney B, Williamson J.

Am J Manag Care. 2007 Jan;13(1):29-35.

6.

Frequent toxicity from IV aminophylline infusions in critically ill patients. 1977.

Hendeles L, Bighley L, Richardson RH, Hepler CD, Carmichael J.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1417-23. No abstract available.

PMID:
16868215
7.

Balancing pharmacists' conscientious objections with their duty to serve.

Hepler CD.

J Am Pharm Assoc (2003). 2005 Jul-Aug;45(4):434-6. No abstract available.

PMID:
16128497
8.

A pharmacist model of perceived responsibility for drug therapy outcomes.

Planas LG, Kimberlin CL, Segal R, Brushwood DB, Hepler CD, Schlenker BR.

Soc Sci Med. 2005 May;60(10):2393-403. Epub 2004 Dec 9.

PMID:
15748686
9.

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.

Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett K, Stayrook KR.

Mol Pharmacol. 2005 Mar;67(3):948-54. Epub 2004 Dec 15.

PMID:
15602004
10.

Clinical pharmacy, pharmaceutical care, and the quality of drug therapy.

Hepler CD.

Pharmacotherapy. 2004 Nov;24(11):1491-8. Review.

PMID:
15537552
11.

T0901317 is a dual LXR/FXR agonist.

Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP.

Mol Genet Metab. 2004 Sep-Oct;83(1-2):184-7.

PMID:
15464433
12.

Preventable drug-related morbidity in older adults 1. Indicator development.

Mackinnon NJ, Hepler CD.

J Manag Care Pharm. 2002 Sep-Oct;8(5):365-71.

13.
14.

Critically examining pharmaceutical care.

Hepler CD, Strand LM, Tromp D, Sakolchai S.

J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5 Suppl 1):S18-9.

PMID:
12296538
15.

Preventing drug-related morbidity--determining valid indicators.

Morris CJ, Cantrill JA, Hepler CD, Noyce PR.

Int J Qual Health Care. 2002 Jun;14(3):183-98.

PMID:
12108529
16.

Preventable drug-related hospital admissions.

Winterstein AG, Sauer BC, Hepler CD, Poole C.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1238-48.

PMID:
12086559
17.

Did viewpoint mischaracterize Danish TOM methods?

Herborg H, Hepler CD.

J Am Pharm Assoc (Wash). 2001 Nov-Dec;41(6):792-3. No abstract available.

PMID:
11765100
18.

Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications.

Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H, Froekjaer B.

J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):551-9.

PMID:
11486981
19.

Improving drug therapy for patients with asthma--part 1: Patient outcomes.

Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau TJ, Ersboell BK.

J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):539-50.

PMID:
11486980
20.

Regulating for outcomes as a systems response to the problem of drug-related morbidity.

Hepler CD.

J Am Pharm Assoc (Wash). 2001 Jan-Feb;41(1):108-15.

PMID:
11216101
21.

Can you help us build our town?

Hepler CD.

Pharmacotherapy. 2000 Aug;20(8):895-7. No abstract available.

PMID:
10939549
22.

Observations on the conference: a pharmacist's perspective.

Hepler CD.

Am J Health Syst Pharm. 2000 Mar 15;57(6):590-4. No abstract available.

PMID:
10754770
23.

[Quality assurance of drug therapy for patients with asthma. Health economic analysis].

Søndergaard B, Thorleifsson S, Herborg H, Frøkjaer B, Hepler CD, Ersbøll BK.

Ugeskr Laeger. 2000 Jan 24;162(4):480-6. Danish.

PMID:
10697444
24.

Preparing pharmacists for pharmaceutical care.

Nau DP, Grainger-Rousseau TJ, Doty R, Hepler CD, Reid LD, Segal R.

J Am Pharm Assoc (Wash). 1998 Nov-Dec;38(6):644-5. No abstract available.

PMID:
9882146
25.

Alpha-lactalbumin as a modulator of mammary cellular activity.

Alston-Mills B, Hepler CD, Sternhagen L, Allen JC, Meshaw KA.

In Vitro Cell Dev Biol Anim. 1998 Nov-Dec;34(10):747-50. No abstract available.

PMID:
9870521
26.

Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy.

Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R.

J Am Pharm Assoc (Wash). 1997 Nov-Dec;NS37(6):647-61.

PMID:
9425794
27.

Looking toward a market for pharmaceutical care.

Hepler CD.

J Am Pharm Assoc (Wash). 1997 Nov-Dec;NS37(6):625-6. No abstract available.

PMID:
9425788
28.

The Pharmacists' Implementation of Pharmaceutical Care (PIPC) model.

Odedina FT, Hepler CD, Segal R, Miller D.

Pharm Res. 1997 Feb;14(2):135-44.

PMID:
9090699
29.

Where is the evidence for formulary effectiveness?

Hepler CD.

Am J Health Syst Pharm. 1997 Jan 1;54(1):95. No abstract available.

PMID:
9117798
30.

Pharmaceutical care.

Hepler CD.

Pharm World Sci. 1996 Dec;18(6):233-5.

PMID:
9010887
31.

Pharmaceutical care versus traditional drug treatment. Is there a difference?

Hepler CD, Grainger-Rousseau TJ.

Drugs. 1995 Jan;49(1):1-10. Review. No abstract available.

PMID:
7705209
32.

Can a community pharmacist add value to prescriptions?

Hepler CD.

Am Pharm. 1993 Mar;NS33(3):46-7. No abstract available.

PMID:
8475847
33.

Pharmaceutical care and specialty practice.

Hepler CD.

Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):64S-69S.

PMID:
8474942
34.

Clozapine and the outmoded drug use process.

Hepler CD.

Am Pharm. 1990 Dec;NS30(12):39-40. Review. No abstract available.

PMID:
2275454
35.

The future of pharmacy: pharmaceutical care.

Hepler CD.

Am Pharm. 1990 Oct;NS30(10):23-9. No abstract available.

PMID:
2239687
36.

Opportunities and responsibilities in pharmaceutical care.

Hepler CD, Strand LM.

Am J Hosp Pharm. 1990 Mar;47(3):533-43.

PMID:
2316538
37.

Effect of acute and chronic terfenadine on free and total serum phenytoin concentrations in epileptic patients.

Coniglio AA, Garnett WR, Pellock JH, Tsidonis O, Hepler CD, Serafin R, Small RE, Driscoll SM, Karnes HT.

Epilepsia. 1989 Sep-Oct;30(5):611-6.

PMID:
2571498
38.

Economic consequences of two drug-use control systems in a teaching hospital.

Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L.

Am J Hosp Pharm. 1988 Nov;45(11):2329-40.

PMID:
3228089
39.

Unresolved issues in the future of pharmacy.

Hepler CD.

Am J Hosp Pharm. 1988 May;45(5):1071-81. Review.

PMID:
3041805
40.

Economic aspects of clinical decision making: evaluating clinical programs.

Hepler CD.

Am J Hosp Pharm. 1988 Mar;45(3):554-60.

PMID:
3369458
41.

Career patterns of pioneer clinical pharmacists.

Angaran DM, Hepler CD, Bjornson DC, Hadsall RS.

Am J Hosp Pharm. 1988 Jan;45(1):101-8.

PMID:
3348221
42.

The third wave in pharmaceutical education: the clinical movement.

Hepler CD.

Am J Pharm Educ. 1987 Winter;51(4):369-85. Review. No abstract available.

PMID:
10302396
43.

Dialogues with hospital pharmacists.

Hepler CD.

Curr Concepts Hosp Pharm Manage. 1987 Winter;9(4):15-8. No abstract available.

PMID:
10284438
44.
45.

Controversies in antimicrobial therapy: critical analysis of clinical trials.

Polk RE, Hepler CD.

Am J Hosp Pharm. 1986 Mar;43(3):630-40.

PMID:
3706318
46.

Improving patient-oriented pharmacy services: panel discussion.

Hepler CD, Lucarotti RL, Rehder TL, Slotfeldt ML.

Am J Hosp Pharm. 1985 Sep;42(9):1950-6.

PMID:
4050812
47.

Drug choice as a problem-solving process.

Segal R, Hepler CD.

Med Care. 1985 Aug;23(8):967-76.

PMID:
4021581
48.

Pharmacy as a clinical profession.

Hepler CD.

Am J Hosp Pharm. 1985 Jun;42(6):1298-306. No abstract available.

PMID:
4014245
49.

Effect of an automated bedside dispensing machine on medication errors.

Barker KN, Pearson RE, Hepler CD, Smith WE, Pappas CA.

Am J Hosp Pharm. 1984 Jul;41(7):1352-8.

PMID:
6465150
50.

Motivating pharmacy personnel: a managerial framework.

Hepler CD, Segal R.

Top Hosp Pharm Manage. 1983 May;3(1):10-36. No abstract available.

PMID:
10314004

Supplemental Content

Loading ...
Support Center